ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | – | 19,025 | +11865.4% | 0.00% | – |
| Q2 2023 | $0 | – | 159 | +448.3% | 0.00% | – |
| Q1 2023 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 29 | -66.7% | 0.00% | – |
| Q3 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 87 | +3.6% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 84 | -97.2% | 0.00% | – |
| Q1 2021 | $16,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2020 | $16,000 | +60.0% | 3,000 | +200.0% | 0.00% | – |
| Q2 2020 | $10,000 | +66.7% | 1,000 | -48.6% | 0.00% | – |
| Q1 2020 | $6,000 | +100.0% | 1,946 | -36.3% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 3,054 | +52.7% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 2,000 | -8.9% | 0.00% | – |
| Q1 2019 | $10,000 | -16.7% | 2,196 | +9.8% | 0.00% | – |
| Q4 2018 | $12,000 | -14.3% | 2,000 | +100.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +9.1% | 1,000 | -1.6% | 0.00% | – |
| Q1 2018 | $11,000 | – | 1,016 | +1463.1% | 0.00% | – |
| Q4 2017 | $0 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |